ADVERTISEMENT
ICICI Securities: GSK Pharma Sees Sequential Growth As Business Recovers From Covid-19 Impact
GSK Pharma’s better-than-expected performance in Q2 was driven by steady recovery of top brands in the aftermath of the lockdown.
29 Oct 2020, 01:47 PM IST 
A logo sits on a metal security gate outside GlaxoSmithKline Plc’s headquarters in London, U.K. (Photographer: Chris Ratcliffe/Bloomberg)
BQ Blue’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer BloombergQuint’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.
I’m already a Subscriber Sign In
To continue reading this storySubscribe to unlock & enjoy all Members-only benefits
Choose a plan
Renews automatically. Cancel anytime.
As a Subscriber you get
Full Access to
NDTV Profit App
Exclusives
Premium Stories
Access to
Stories
Curated
Newsletters
20,000+
Research Reports
Priority Pass
to Special Events
Ad-Free
Experience
Members-Only
Rewards
Still Not convinced ? Know More
